Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes.

Authors:
Loponen N; Ylä-Outinen H; Kallionpää RA; Valtanen M; Auranen K and 3 more

Journal:
Mol Genet Genomic Med

Publication Year: 2023

DOI:
10.1002/mgg3.2346

PMCID:
PMC10767585

PMID:
38131619

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Mol Genet Genomic Med

Abbreviation: Mol Genet Genomic Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Genetics, Medical

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A novel gain-of-function STAT3 variant in infantile-onset diabetes associated with multiorgan autoi…
Zhou Q; Chen D; Yu J and 5 more (2024) - Transparency Score: 1/6
A novel heterozygous mutation in PTHLH causing autosomal dominant brachydactyly type E complicated …
Sun J; Yang N; Xu Z and 2 more (2024) - Transparency Score: 3/6
A novel intronic variant causing aberrant splicing identified in two deaf Chinese siblings with enl…
Wang S; Zhu YM; Xu C and 6 more (2024) - Transparency Score: 3/6
Antenatal description of large 4q13.2q21.23 deletion and outcomes.
Giguet-Valard AG; Thevenin C; Dreux S and 7 more (2024) - Transparency Score: 4/6
Association of Y chromosome AZF region microdeletions with recurrent miscarriage in Iranian couples…
Pazoki N; Salehi M; Angaji SA and 1 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest."

Evidence found in paper:

"The study was funded with grants from the Cancer Foundation Finland and Turku University Hospital. This study has been carried out in Turku University Hospital which is a member of the European Reference Network on Genetic Tumor Risk Syndromes (ERN GENTURIS). ERN GENTURIS is funded by the European Union."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025